2024 Q2 Form 10-Q Financial Statement

#000089772324000031 Filed on May 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.841B $1.835B
YoY Change -20.63%
Cost Of Revenue $1.688B $1.680B
YoY Change -20.72%
Gross Profit $153.5M $154.8M
YoY Change -19.69%
Gross Profit Margin 8.34% 8.44%
Selling, General & Admin $61.72M $69.20M
YoY Change -2.63%
% of Gross Profit 40.2% 44.71%
Research & Development $7.659M $6.323M
YoY Change 19.78%
% of Gross Profit 4.99% 4.09%
Depreciation & Amortization $29.76M $30.27M
YoY Change 1.65%
% of Gross Profit 19.39% 19.56%
Operating Expenses $71.17M $75.52M
YoY Change 0.83%
Operating Profit $82.37M $79.23M
YoY Change -31.7%
Interest Expense -$4.934M -$4.806M
YoY Change -153.13%
% of Operating Profit -5.99% -6.07%
Other Income/Expense, Net -$7.729M $3.276M
YoY Change -18.77%
Pretax Income $74.64M $74.43M
YoY Change -32.81%
Income Tax $20.00M $19.12M
% Of Pretax Income 26.8% 25.69%
Net Earnings $51.60M $52.49M
YoY Change -35.19%
Net Earnings / Revenue 2.8% 2.86%
Basic Earnings Per Share $0.93 $0.94
Diluted Earnings Per Share $0.91 $0.93
COMMON SHARES
Basic Shares Outstanding 55.45M shares 55.78M shares
Diluted Shares Outstanding 56.71M shares 56.70M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $657.7M $650.9M
YoY Change -8.42%
Cash & Equivalents $657.7M $650.9M
Short-Term Investments
Other Short-Term Assets $81.66M $75.05M
YoY Change 18.18%
Inventory $1.384B $1.384B
Prepaid Expenses
Receivables $1.570B $1.588B
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.693B $3.697B
YoY Change -8.47%
LONG-TERM ASSETS
Property, Plant & Equipment $630.3M $726.6M
YoY Change 2.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $177.2M $262.2M
YoY Change -2.29%
Total Long-Term Assets $970.2M $988.8M
YoY Change -2.44%
TOTAL ASSETS
Total Short-Term Assets $3.693B $3.697B
Total Long-Term Assets $970.2M $988.8M
Total Assets $4.664B $4.686B
YoY Change -7.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.434B $1.443B
YoY Change -21.59%
Accrued Expenses $370.3M $387.3M
YoY Change -9.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $17.50M $17.50M
YoY Change 0.0%
Total Short-Term Liabilities $1.822B $1.848B
YoY Change -19.22%
LONG-TERM LIABILITIES
Long-Term Debt $299.7M $303.9M
YoY Change -6.58%
Other Long-Term Liabilities $201.0M $207.5M
YoY Change -14.73%
Total Long-Term Liabilities $500.6M $511.4M
YoY Change -10.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.822B $1.848B
Total Long-Term Liabilities $500.6M $511.4M
Total Liabilities $2.322B $2.515B
YoY Change -17.4%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.341B $2.171B
YoY Change
Total Liabilities & Shareholders Equity $4.664B $4.686B
YoY Change -7.28%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $51.60M $52.49M
YoY Change -35.19%
Depreciation, Depletion And Amortization $29.76M $30.27M
YoY Change 1.65%
Cash From Operating Activities $90.00M $72.32M
YoY Change 39.36%
INVESTING ACTIVITIES
Capital Expenditures $22.77M $29.61M
YoY Change -64.37%
Acquisitions
YoY Change
Other Investing Activities -$600.0K -$700.0K
YoY Change 150.0%
Cash From Investing Activities -$23.37M -$30.31M
YoY Change -63.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -59.00M -21.85M
YoY Change 232.4%
NET CHANGE
Cash From Operating Activities 90.00M 72.32M
Cash From Investing Activities -23.37M -30.31M
Cash From Financing Activities -59.00M -21.85M
Net Change In Cash 7.623M 20.15M
YoY Change -143.98%
FREE CASH FLOW
Cash From Operating Activities $90.00M $72.32M
Capital Expenditures $22.77M $29.61M
Free Cash Flow $67.23M $42.71M
YoY Change 10085.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Interest Expense
InterestExpense
8218000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
9286000 usd
us-gaap Interest Expense
InterestExpense
16630000 usd
us-gaap Interest Expense
InterestExpense
17967000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LiabilitiesTotalMember
CY2023Q3 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LiabilitiesTotalMember
us-gaap Fiscal Period
FiscalPeriod
The Company operates on a 52 or 53 week year ending on the Saturday nearest September 30. Fiscal 2024 and 2023 are each 52-week years. All references to years relate to fiscal years unless otherwise noted.
us-gaap Repayments Of Debt
RepaymentsOfDebt
17195000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
8750000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1410300000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1410300000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1471700000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
293000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
295000 usd
sanm Repurchases Of Common Stock Including Excise Tax
RepurchasesOfCommonStockIncludingExciseTax
133389000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21507000 usd
sanm Proceeds From Sale Of Noncontrolling Interest
ProceedsFromSaleOfNoncontrollingInterest
0 usd
sanm Proceeds From Sale Of Noncontrolling Interest
ProceedsFromSaleOfNoncontrollingInterest
215799000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-150291000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
185837000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
364000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2195000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16712000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
188346000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
667570000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
529857000 usd
us-gaap Interest Paid Net
InterestPaidNet
15143000 usd
us-gaap Interest Paid Net
InterestPaidNet
15264000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
38550000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
28247000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
30598000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
34973000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations for the second quarter of 2024 are not necessarily indicative of the results that may be expected for other interim periods or for the full fiscal year.</span></div>
sanm Percentof Net Sales Transferred Over Time
PercentofNetSalesTransferredOverTime
0.95
CY2024Q1 sanm Raw Materials As A Percentage Of Total Inventory
RawMaterialsAsAPercentageOfTotalInventory
0.99
sanm Number Of Other Operating Segment Excluding Das
NumberOfOtherOperatingSegmentExcludingDAS
13
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1834595000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2320103000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1834595000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2320103000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1834595000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2320103000 usd
sanm Percentage Of Net Sales Represented By Ten Largest Customers
PercentageOfNetSalesRepresentedByTenLargestCustomers
0.50
sanm Cash Equivalents
CashEquivalents
0.10
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
8000000 usd
CY2023Q4 us-gaap Income Tax Examination Estimate Of Possible Loss
IncomeTaxExaminationEstimateOfPossibleLoss
8000000 usd
CY2023Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
503000000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
303884000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
312327000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
85569000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
95750000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
22279000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
22344000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
51327000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
60663000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
73606000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
83007000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y1M20D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y11M19D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.040
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2024Q1 sanm Operating Leases Rent Expense Net Of Sublease Income
OperatingLeasesRentExpenseNetOfSubleaseIncome
8073000 usd
CY2023Q2 sanm Operating Leases Rent Expense Net Of Sublease Income
OperatingLeasesRentExpenseNetOfSubleaseIncome
8198000 usd
sanm Operating Leases Rent Expense Net Of Sublease Income
OperatingLeasesRentExpenseNetOfSubleaseIncome
16245000 usd
sanm Operating Leases Rent Expense Net Of Sublease Income
OperatingLeasesRentExpenseNetOfSubleaseIncome
17565000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
12997000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
11629000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
12907000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
22987000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
17741000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
13850000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4466000 usd
CY2024Q1 sanm Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
8879000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
80830000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7224000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
73606000 usd
CY2024Q1 sanm Face Valueof Receivable Sold Percentage
FaceValueofReceivableSoldPercentage
1
sanm Accounts Receivable Sold During The Period
AccountsReceivableSoldDuringThePeriod
797000000 usd
sanm Accounts Receivable Sold During The Period
AccountsReceivableSoldDuringThePeriod
1700000000 usd
sanm Discount On Sold Receivables
DiscountOnSoldReceivables
5000000 usd
sanm Discount On Sold Receivables
DiscountOnSoldReceivables
12000000 usd
CY2024Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
40000000 usd
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
34000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.26
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
70089000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
68305000 usd
CY2024Q1 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
6169000 usd
CY2023Q3 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
9427000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
6725000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
6853000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
69533000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
70879000 usd
sanm Shares Repurchased
SharesRepurchased
2000000 shares
sanm Shares Repurchased
SharesRepurchased
4000 shares
sanm Share Repurchases
ShareRepurchases
107000000 usd
sanm Share Repurchases
ShareRepurchases
200000 usd
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
172000000 usd
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
500000 shares
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
400000 shares
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
25000000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
21000000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1834595000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2320103000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3709393000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4675911000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
154757000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
191189000 usd
us-gaap Gross Profit
GrossProfit
315597000 usd
us-gaap Gross Profit
GrossProfit
386575000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
52485000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
79621000 usd
us-gaap Net Income Loss
NetIncomeLoss
109553000 usd
us-gaap Net Income Loss
NetIncomeLoss
171635000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55585000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58269000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56062000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57999000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1114000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1550000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1408000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1864000 shares
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56699000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59819000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57470000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59863000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.94
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.96
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.93
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.87
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
14651000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
12534000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
27236000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
24143000 usd
CY2024Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
6000000 shares
CY2024Q1 sanm Stock Options And Unvested Restricted Stock Units Outstanding
StockOptionsAndUnvestedRestrictedStockUnitsOutstanding
3000000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3000000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2881000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
45.07
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y1M20D
CY2023Q3 sanm Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
150547000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1389000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
51.44
sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndCancelled
1368000 shares
sanm Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Vested And Cancelled Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndCancelledWeightedAverageGrantDateFairValue
40.22
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2902000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
50.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y7M9D
CY2024Q1 sanm Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
170722000 usd
CY2024Q1 sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested And Expected To Vest Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAndExpectedToVestNumber
2547000 shares
CY2024Q1 sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested And Expected To Vest Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAndExpectedToVestWeightedAverageGrantDateFairValue
50.30
sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested And Expected To Vest Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAndExpectedToVestWeightedAverageRemainingContractualTerm
P1Y6M29D
CY2024Q1 sanm Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Nonvested And Expected To Vest Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNonvestedAndExpectedToVestAggregateIntrinsicValue
149835000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
106000000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M6D

Files In Submission

Name View Source Status
0000897723-24-000031-index-headers.html Edgar Link pending
0000897723-24-000031-index.html Edgar Link pending
0000897723-24-000031.txt Edgar Link pending
0000897723-24-000031-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sanm-20240330.htm Edgar Link pending
sanm-20240330.xsd Edgar Link pending
sanmina_ex1029x20240330.htm Edgar Link pending
sanmina_ex311x20240330.htm Edgar Link pending
sanmina_ex312x20240330.htm Edgar Link pending
sanmina_ex321x20240330.htm Edgar Link pending
sanmina_ex322x20240330.htm Edgar Link pending
Show.js Edgar Link pending
sanm-20240330_def.xml Edgar Link unprocessable
sanm-20240330_pre.xml Edgar Link unprocessable
sanm-20240330_htm.xml Edgar Link completed
sanm-20240330_lab.xml Edgar Link unprocessable
sanm-20240330_cal.xml Edgar Link unprocessable